The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Peripheral blood cell counts as biomarkers of clinical benefit in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) receiving immune checkpoint inhibitor (ICI) combination (combo) therapies.
 
Ardit Feinaj
No Relationships to Disclose
 
Kaizen Nathani
Employment - CitiusTech
 
Amina Touma
No Relationships to Disclose
 
Roy Elias
No Relationships to Disclose
 
Maximilian Pallauf
(OPTIONAL) Uncompensated Relationships - Convergent Genomics (Inst)
 
Mark Christopher Markowski
No Relationships to Disclose
 
Michael Anthony Carducci
Consulting or Advisory Role - Acrivon Therapeutics; AstraZeneca; Pfizer; Sanofi
Speakers' Bureau - Remedica
Research Funding - Arcus Biosciences (Inst); Celgene/Bristol-Myers Squibb (Inst); Merck (Inst); pfizer (Inst)
 
Nirmish Singla
No Relationships to Disclose
 
Yasser Ged
Consulting or Advisory Role - AVEO; BostonGene; Bristol Myers Squibb; Eisai; Exelixis; Targeted Oncology; Targeted Oncology